Source:http://linkedlifedata.com/resource/pubmed/id/10717417
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2000-4-19
|
pubmed:abstractText |
The novel dimer bis(7)-tacrine (1,7-N-Heptylene-bis-9,9'-amino-1,2,3, 4-tetrahydroacridine), which exhibits higher potency, selectivity and oral activity on acetylcholinesterase inhibition in vivo than tacrine, was evaluated for its ability to reverse AF64A-induced spatial memory impairment in rats using the Morris water maze. The intracerebroventricular injection of AF64A (3 nmol/side) resulted in a substantial increase in the escape latency to find the platform (F(1,7)=30.2, P<0.01). The observed impairment of spatial memory was paralleled by a 47% decrease in choline acetyltransferase activity in the hippocampus. Oral administration of bis(7)-tacrine (0.22-0.89 micromol/kg) dose-dependently reversed the AF64A-induced latency delay to the level of the saline control group (F(4,28)=7.45, P<0. 05). The present study provides additional evidence of bis(7)-tacrine as an ideal candidate for the palliative treatment of Alzheimer's disease.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/1,7-N-heptylene-bis-9,9'-amino-1,2,3...,
http://linkedlifedata.com/resource/pubmed/chemical/Aziridines,
http://linkedlifedata.com/resource/pubmed/chemical/Choline,
http://linkedlifedata.com/resource/pubmed/chemical/Cholinesterase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Tacrine,
http://linkedlifedata.com/resource/pubmed/chemical/Toxins, Biological,
http://linkedlifedata.com/resource/pubmed/chemical/ethylcholine aziridinium
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0304-3940
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
24
|
pubmed:volume |
282
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
165-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10717417-Animals,
pubmed-meshheading:10717417-Aziridines,
pubmed-meshheading:10717417-Choline,
pubmed-meshheading:10717417-Cholinesterase Inhibitors,
pubmed-meshheading:10717417-Escape Reaction,
pubmed-meshheading:10717417-Injections, Intraventricular,
pubmed-meshheading:10717417-Male,
pubmed-meshheading:10717417-Maze Learning,
pubmed-meshheading:10717417-Memory,
pubmed-meshheading:10717417-Rats,
pubmed-meshheading:10717417-Rats, Sprague-Dawley,
pubmed-meshheading:10717417-Reaction Time,
pubmed-meshheading:10717417-Tacrine,
pubmed-meshheading:10717417-Toxins, Biological
|
pubmed:year |
2000
|
pubmed:articleTitle |
Bis(7)-tacrine, a novel acetylcholinesterase inhibitor, reverses AF64A-induced deficits in navigational memory in rats.
|
pubmed:affiliation |
Department of Biochemistry, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|